Manhattan Scientifics, Inc.
MHTX
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.06M | -1.13M | -1.17M | -1.31M | -1.12M |
| Total Depreciation and Amortization | 0.00 | 1.00K | 1.00K | 2.00K | 2.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 1.00K | 7.00K |
| Total Other Non-Cash Items | 373.00K | 418.00K | 462.00K | 580.00K | 394.00K |
| Change in Net Operating Assets | 573.00K | 551.00K | 512.00K | 461.00K | 399.00K |
| Cash from Operations | -110.00K | -157.00K | -190.00K | -263.00K | -314.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.00K | 128.00K | 102.00K | 114.00K | 30.00K |
| Cash from Investing | 106.00K | 128.00K | 102.00K | 114.00K | 30.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.00K | -10.00K | -20.00K | -50.00K | -50.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -10.00K | -10.00K | -20.00K | -50.00K | -50.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.00K | -39.00K | -108.00K | -199.00K | -334.00K |